3.27
price down icon5.49%   -0.19
after-market Handel nachbörslich: 3.27
loading
Schlusskurs vom Vortag:
$3.46
Offen:
$3.38
24-Stunden-Volumen:
1.42M
Relative Volume:
0.61
Marktkapitalisierung:
$554.34M
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-1.1679
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+2.19%
1M Leistung:
-18.45%
6M Leistung:
-63.67%
1J Leistung:
-68.31%
1-Tages-Spanne:
Value
$3.19
$3.44
1-Wochen-Bereich:
Value
$3.15
$3.525
52-Wochen-Spanne:
Value
$3.02
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Firmenname
Relay Therapeutics Inc
Name
Telefon
617-370-8837
Name
Adresse
399 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
261
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-21
Name
Neueste SEC-Einreichungen
Name
RLAY's Discussions on Twitter

Vergleichen Sie RLAY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
RLAY
Relay Therapeutics Inc
3.27 554.34M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.01 128.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
744.83 81.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
571.00 34.69B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.07 30.17B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.66 26.02B 3.32B -860.46M -1.04B -8.32

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-09-10 Fortgesetzt Goldman Buy
2024-09-10 Hochstufung Jefferies Hold → Buy
2024-09-10 Herabstufung Oppenheimer Outperform → Perform
2024-05-10 Hochstufung Barclays Equal Weight → Overweight
2023-04-20 Hochstufung Jefferies Underperform → Hold
2023-04-19 Hochstufung Raymond James Outperform → Strong Buy
2023-04-13 Eingeleitet Raymond James Outperform
2023-02-03 Eingeleitet Oppenheimer Outperform
2022-09-30 Eingeleitet Barclays Equal Weight
2022-09-02 Eingeleitet Stifel Buy
2022-06-06 Eingeleitet Jefferies Underperform
2022-02-01 Eingeleitet Berenberg Buy
2021-07-21 Eingeleitet BofA Securities Buy
2020-12-15 Bestätigt H.C. Wainwright Buy
2020-12-08 Eingeleitet JMP Securities Mkt Outperform
2020-11-05 Eingeleitet H.C. Wainwright Buy
2020-08-10 Eingeleitet Cowen Outperform
2020-08-10 Eingeleitet Goldman Buy
2020-08-10 Eingeleitet Guggenheim Buy
2020-08-10 Eingeleitet JP Morgan Neutral
Alle ansehen

Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten

pulisher
Mar 10, 2025

Relay Therapeutics’ (RLAY) Buy Rating Reiterated at HC Wainwright - Armenian Reporter

Mar 10, 2025
pulisher
Mar 09, 2025

HC Wainwright Reiterates “Buy” Rating for Relay Therapeutics (NASDAQ:RLAY) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Acquires 13,532 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Has $121,000 Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Down -31.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Relay Therapeutics (RLAY) - Yahoo Finance

Mar 05, 2025
pulisher
Mar 02, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

The Goldman Sachs Group Lowers Relay Therapeutics (NASDAQ:RLAY) Price Target to $18.00 - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year Low After Analyst Downgrade - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Relay Therapeutics price target lowered to $12 from $21 at Citizens JMP - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Relay Therapeutics stock target cut to $12 at Citizens JMP - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

RLAY stock touches 52-week low at $3.34 amid market challenges - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Relay Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Relay Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics reports Q4 EPS (45c), consensus (55c) - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 25, 2025

What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnin - GuruFocus.com

Feb 25, 2025
pulisher
Feb 25, 2025

What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - WICZ

Feb 24, 2025
pulisher
Feb 24, 2025

Can These Two Major Healthcare Conferences Reveal Relay Therapeutics' Next Big Move? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Feb 23, 2025
pulisher
Feb 20, 2025

Savant Capital LLC Buys Shares of 29,088 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Feb 20, 2025
pulisher
Feb 20, 2025

Relay Therapeutics (RLAY) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 20, 2025
pulisher
Feb 20, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 - The Manila Times

Feb 20, 2025
pulisher
Feb 19, 2025

The Potential Rise in the Price of Relay Therapeutics Inc (RLAY) following insiders activity - Knox Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and ... - The Bakersfield Californian

Feb 19, 2025
pulisher
Feb 16, 2025

This Insider Has Just Sold Shares In Relay Therapeutics - Simply Wall St

Feb 16, 2025
pulisher
Feb 15, 2025

Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Relay Therapeutics (NASDAQ:RLAY) Shares Gap DownTime to Sell? - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sanjiv Patel Sells 75,324 Shares - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sells 140,182 Shares of Stock - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Relay Therapeutics: A Precision Oncology Play Worth The Risk - Seeking Alpha

Feb 14, 2025
pulisher
Feb 13, 2025

Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock By Investing.com - Investing.com UK

Feb 13, 2025
pulisher
Feb 13, 2025

Q2 Earnings Forecast for RLAY Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 11, 2025

Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down – Should You Sell? - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

Q2 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Quarterly Metrics: Quick and Current Ratios for Relay Therapeutics Inc (RLAY) - The Dwinnex

Feb 10, 2025
pulisher
Feb 08, 2025

Brokers Issue Forecasts for RLAY Q1 Earnings - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

RLAY’s Market Whiplash: 9.47% YTD Rise, -1.31% Plunge in 30 Days - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Analysts Set Expectations for RLAY Q1 Earnings - Armenian Reporter

Feb 07, 2025
pulisher
Feb 06, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Expands Stake in Relay Therapeutics Inc with Sig - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

SG Americas Securities LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Brokerages - ETF Daily News

Feb 05, 2025
pulisher
Feb 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

How should investors view Relay Therapeutics Inc (RLAY)? - US Post News

Feb 04, 2025

Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$35.96
price up icon 0.98%
$21.98
price down icon 8.97%
$32.75
price down icon 0.79%
$317.87
price up icon 0.62%
$105.35
price down icon 3.15%
biotechnology ONC
$242.66
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):